Equity Details
Price & Market Data
Price: $0.0893
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,888,520
Daily Volume: 0
Performance Metrics
1 Week: -16.42%
1 Month: 24.03%
3 Months: -34.08%
6 Months: -19.26%
1 Year: -72.27%
YTD: 14.12%
About RAKOVINA THERAPEUTICS INC (RKVTF)
Uncover market data for RAKOVINA THERAPEUTICS INC (RKVTF). Price: 0.0893, daily change: $0.00 / 0.00%. Market cap: 1,888,520. Performance from 1-week to 6-month.
Details
Rakovina Therapeutics Inc., a biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets. The company's preclinical product pipeline include kt-2000AI, an poly(ADP)-ribose polymerase (PARP) brain penetrant cancer therapy; kt-3000, a bi-functional small-molecule drug candidate; kt-3283 series for the treatment of PARP resistant adult and childhood cancers; and kt-4000, a DNA-damaging DDR inhibitors. It has a research collaboration with Variational AI Inc. to identify and develop novel small-molecule therapies against DNA-damage response (DDR) targets for the treatment of cancer. Additionally, it signed a letter of intent with NanoPalm Ltd. to form a joint venture to co-develop novel small-molecule oncology therapeutics. The company was formerly known as Vincero Capital Corp. Rakovina Therapeutics Inc. is headquartered in Vancouver, Canada.